Jens C. Hahne

Josef Schneider Str. 4
Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications

Discovery of actionable drug targets to enhance T-cell infiltration and immune checkpoint blockade efficacy in pleural mesothelioma.

Discovery of actionable drug targets to enhance T-cell infiltration and immune checkpoint blockade efficacy in pleural mesothelioma.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 27, 2025

Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer.

Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer.

Journal: Nature communications
Published: June 01, 2025

Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial.

Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial.

Journal: Nature communications
Published: October 11, 2024

Emerging Therapeutic Targets and Future Directions in Advanced Gastric Cancer: A Comprehensive Review.

Emerging Therapeutic Targets and Future Directions in Advanced Gastric Cancer: A Comprehensive Review.

Journal: Cancers
Published: June 28, 2024

Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy.

Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 30, 2024

A flexible beamline combining XUV attosecond pulses with few-femtosecond UV and near-infrared pulses for time-resolved experiments.

A flexible beamline combining XUV attosecond pulses with few-femtosecond UV and near-infrared pulses for time-resolved experiments.

Journal: The Review of scientific instruments
Published: December 09, 2023

Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.

Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 16, 2023

A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma.

A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma.

Journal: Nature communications
Published: October 04, 2023

Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment.

Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment.

Journal: Biomedicines
Published: August 31, 2023

Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies.

Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies.

Journal: Journal of clinical medicine
Published: February 16, 2023

Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience.

Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience.

Journal: Journal of clinical medicine
Published: October 31, 2022

Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling.

Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling.

Journal: Frontiers in endocrinology
Published: December 13, 2021
Showing 1-12 of 65

Last Updated: 09/26/2026